Moneycontrol
HomeNewsIndiaCoronavirus News Highlights: Chhattisgarh rejects Bharat Biotech vaccine approved without efficacy data

Coronavirus News Highlights: Chhattisgarh rejects Bharat Biotech vaccine approved without efficacy data

Coronavirus News Highlights: More than 1.08 crore confirmed COVID-19 cases, including 1.55 lakh deaths, have been recorded in India. Over 66 lakh people have been given their first COVID-19 vaccine dose so far

February 11, 2021 / 22:59 IST
Story continues below Advertisement

Coronavirus News Highlights: Today is the 323rd day since India implemented a nationwide lockdown to help curb the novel coronavirus pandemic. So far, India has recorded more than 1.08 crore confirmed COVID-19 cases, including over 1.55 lakh deaths. A total of 1.05 crore people have recuperated from COVID-19 in the country so far. However, there are 1.48 lakh active cases. India's recovery rate continues to rise and now stands at 97.16 percent. Globally, over 10.71 crore people have been infected by the novel coronavirus and 23.45 lakh have died so far. India, along with many countries, has granted emergency use authorization for COVID-19 vaccines and has started the process of vaccinating healthcare workers and high-risk groups. India's regulator has granted restricted emergency use approval for two vaccines -- Covishield and Covaxin. More than 66 lakh people have been given their first dose of the COVID-19 vaccine in India so far.

February 11, 2021 / 22:56 IST

This LIVE blog session has concluded. Stay tuned to Moneycontrol for the latest news, views and updates.

February 11, 2021 / 21:33 IST

Coronavirus Live updates | Union Health Minister Dr Harsh Vardhan:

Central Drugs Standards & Control Org, headed by DCGI, has granted permission to manufacture 2 COVID-19 vaccines based on the prescribed procedure & after due evaluation of pre-clinical & clinical trial data.

Story continues below Advertisement
February 11, 2021 / 21:31 IST

Coronavirus Live updates | Union Health Minister Dr Harsh Vardhan:

Only Covishield & Covaxin are being used for vaccination drive in country. Both vaccines being supplied to States/UTs are safe & immunogenic & should be used expeditiously to rapidly confer protection to prioritised beneficiaries.

February 11, 2021 / 20:58 IST

Coronavirus Live updates | 285 new COVID-19 cases, 2 deaths, no new case in 13 districts

Gujarat recorded 285 new coronavirus cases and two deaths in the last 24 hours, the state Health Department said on Thursday evening.
The caseload in the state thus rose to 2,64,450, while the death toll due to the pandemic reached 4,399. Both the latest fatalities were reported from Ahmedabad district.

With 302 patients being discharged, the number of recoveries rose to 2,58,270, the release said.

Gujarat''s rate of recovery went up to 97.66 per cent on Thursday. There are only 1,781 active cases in the state at present, 30 of them are on ventilators.

February 11, 2021 / 20:50 IST

Coronavirus Live updates | DGP among 72,204 frontline workers vaccinated so far in Himachal

As many as 6,090 frontline workers including Director general of Police Sanjay Kundu were administered the COVID-19 vaccine in Himachal Pradesh on Thursday, taking the number of people who have received the jabs in the state so far to 72,204, a senior health official said.
The number of frontline workers receiving the jab has increased to 10,915 after beginning of the second phase of the vaccination drive on Wednesday.

Earlier, 61,289 healthcare workers had been vaccinated in 1,133 sessions during the first phase from January 16 to February 9, Special Secretary (Health) Nipun Jindal said.

Story continues below Advertisement
February 11, 2021 / 19:40 IST

Coronavirus Live updates | Not perfect, but saves lives, AstraZeneca says as Africa backs COVID-19 shot

AstraZeneca’s COVID-19 vaccine is not perfect, but will have a big impact on the pandemic, its chief executive predicted on Thursday, as the drugmaker pledged to double output by April and the African Union gave its backing for the shot.

The two-dose inosculation, developed with Oxford University, has been hailed as a “vaccine for the world” because it is cheaper and easier to distribute than some rivals.

But its rapid approval in Europe and elsewhere has been clouded by doubts over its most effective dosage and interval between doses.

Data at the weekend also showed it was less effective against a fast-spreading variant of the virus in South Africa, prompting the country to pause rollout of the shot, and the company has also been embroiled in a row with the European Union over supply delays.

February 11, 2021 / 17:46 IST

Coronavirus Live updates | Chhattisgarh rejects Bharat Biotech vaccine approved without efficacy data

India, which has reported the world’s second-highest number of COVID-19 cases after the United States, has vaccinated more than 7 million front-line workers since January 16 using COVAXIN developed by Bharat Biotech as well as a vaccine licenced from AstraZeneca and Oxford University.

So far the government has ordered 10 million COVAXIN doses and 21 million AstraZeneca shots, locally made by the Serum Institute of India for low- and middle-income countries.

Bharat Biotech, which created COVAXIN with the state-run Indian Council of Medical Research, has said efficacy data from the late-stage clinical trial on nearly 26,000 volunteers will be out by next month, leading to criticism from epidemiologists that it was approved too hastily for emergency use.

February 11, 2021 / 16:34 IST

Coronavirus Live updates | EAM at World Sustainable Development Summit-High Level Round Table on Rebooting Green Growth:

After a year of pandemic, we're seeing optimism around us. COVID-19 may have devastated world economy,causing immeasurable damage. Millions lost their jobs andmany pushed back into poverty.

February 11, 2021 / 16:32 IST

Coronavirus Live updates | Mobile labs for COVID-19 testing to soon be available in Maharashtra: CM

Maharashtra Chief Minister Uddhav Thackeray on Thursday said mobile laboratories for COVID-19 testing will soon be made available across the state.
Speaking at the launch of three laboratory vans for COVID-19 testing, Thackeray said these mobile laboratories can carry out 3,000 tests per day and reports would be available in 24 hours.

Tests will be conducted at the mobile labs for Rs 499, said Mumbai municipal commissioner I S Chahal who was present on the occasion.

The mobile labs by Spice Heath, which are accredited by the National Accreditation Board for Testing and Calibration Laboratories (NABL) and Indian Council of Medical Research (ICMR), have been set up at Bandra Kurla Complex, National Sports Club of India in Worli and NESCO in Goregaon.

February 11, 2021 / 15:54 IST

Coronavirus Live updates | Mexico to receive 1 million doses of Indian-made Covid-19 vaccine, says Prez Lopez Obrador

Mexican President Andres Manuel Lopez Obrador at a news conference on Wednesday informed that the country would receive around a million doses of AstraZeneca's COVID-19 vaccine sent from India in the early hours of Sunday.

Indian envoy to Mexico Manpreet Vohra also announced, "To assist #Mexico's fight against the Covid-19 pandemic, I am delighted to confirm that 500,000 Made-in-India vaccines are scheduled to reach here on Sunday," tweeted the Indian Embassy in Mexico.

Story continues below Advertisement